377 related articles for article (PubMed ID: 24937458)
1. JARID1B is a luminal lineage-driving oncogene in breast cancer.
Yamamoto S; Wu Z; Russnes HG; Takagi S; Peluffo G; Vaske C; Zhao X; Moen Vollan HK; Maruyama R; Ekram MB; Sun H; Kim JH; Carver K; Zucca M; Feng J; Almendro V; Bessarabova M; Rueda OM; Nikolsky Y; Caldas C; Liu XS; Polyak K
Cancer Cell; 2014 Jun; 25(6):762-77. PubMed ID: 24937458
[TBL] [Abstract][Full Text] [Related]
2. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
3. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
[TBL] [Abstract][Full Text] [Related]
4. Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B.
Pippa S; Mannironi C; Licursi V; Bombardi L; Colotti G; Cundari E; Mollica A; Coluccia A; Naccarato V; La Regina G; Silvestri R; Negri R
Molecules; 2019 May; 24(9):. PubMed ID: 31060229
[No Abstract] [Full Text] [Related]
5. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
Huang YQ; Zou Y; Zheng RJ; Ma XD
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
[TBL] [Abstract][Full Text] [Related]
6. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
Mitra D; Das PM; Huynh FC; Jones FE
J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
[TBL] [Abstract][Full Text] [Related]
7. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
[TBL] [Abstract][Full Text] [Related]
8. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.
Kim J; Shin S; Subramaniam M; Bruinsma E; Kim TD; Hawse JR; Spelsberg TC; Janknecht R
Biochem Biophys Res Commun; 2010 Oct; 401(3):412-6. PubMed ID: 20863814
[TBL] [Abstract][Full Text] [Related]
10. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
Wang W; Zheng K; Pei Y; Zhang X
Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
[TBL] [Abstract][Full Text] [Related]
11. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
Xiang Y; Zhu Z; Han G; Ye X; Xu B; Peng Z; Ma Y; Yu Y; Lin H; Chen AP; Chen CD
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19226-31. PubMed ID: 18048344
[TBL] [Abstract][Full Text] [Related]
12. JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer.
Mocavini I; Pippa S; Licursi V; Paci P; Trisciuoglio D; Mannironi C; Presutti C; Negri R
Cancer Sci; 2019 Apr; 110(4):1232-1243. PubMed ID: 30588710
[TBL] [Abstract][Full Text] [Related]
13. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
[TBL] [Abstract][Full Text] [Related]
14. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.
Zou MR; Cao J; Liu Z; Huh SJ; Polyak K; Yan Q
J Biol Chem; 2014 Jun; 289(25):17620-33. PubMed ID: 24802759
[TBL] [Abstract][Full Text] [Related]
16. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
Zhang L; Sokolowski N; Atmadibrata B; Liu T
Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
[TBL] [Abstract][Full Text] [Related]
19. [The effects of JARID1B siRNA on proliferation and apoptosis in HL-60 cell].
Ma XD; Han HD; Huang YQ; Zou Y
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):392-6. PubMed ID: 22781799
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor activation by polychlorinated biphenyls: epigenetic effects mediated by the histone demethylase Jarid1b.
Casati L; Sendra R; Poletti A; Negri-Cesi P; Celotti F
Epigenetics; 2013 Oct; 8(10):1061-8. PubMed ID: 23907094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
